Welcome to our dedicated page for WORK Medical Technology Group SEC filings (Ticker: WOK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the revenue impact of polypropylene price swings or figuring out how new export regulations affect mask sales can turn WORK Medical Technology Group LTD’s disclosures into a time-consuming puzzle. Each 10-K spans hundreds of infection-control details, and every 8-K about raw-material shortages can move the stock within minutes. That complexity is why our page goes far beyond a simple document list.
Stock Titan’s AI reads every WORK Medical Technology Group LTD quarterly earnings report 10-Q filing the moment it hits EDGAR and highlights which segments—KN95 masks, intubation kits, tourniquets—drove the quarter. Need WORK Medical Technology Group LTD insider trading Form 4 transactions? We stream them in real time, flagging executive stock transactions Form 4 alongside context so you see whether management is buying after a big hospital contract. Our summaries translate dense accounting language, giving you WORK Medical Technology Group LTD SEC filings explained simply—from supply-chain risk notes to capacity-expansion capex tables.
Inside this hub you’ll find:
- 10-K annual report data points—PPE revenue mix and regulatory approvals—WORK Medical Technology Group LTD annual report 10-K simplified
- Fresh 8-K material events explained when factories pause or resume production
- Proxy statement executive compensation links to quality-control milestones—WORK Medical Technology Group LTD proxy statement executive compensation
- Form 4 insider transactions real-time alerts for sudden director sales
LifeMD, Inc. (symbol LFMD, common stock) filed a Form 144 indicating that shareholder Schreiber Holdings LLC intends to sell up to 175,000 shares through J.P. Morgan Securities on 01 Aug 2025. At the filing’s stated market value of $1.82 million (≈ $10.41 per share), the transaction equals about 0.4 % of the 45.45 million shares outstanding.
The seller originally acquired the stock on 25 Apr 2019 in an asset-for-equity exchange with the issuer. Over the past three months, the same holder has already disposed of 53,005 shares for gross proceeds of $668,651, signalling an ongoing liquidation programme.
No operating or financial performance data is provided; the notice is solely to comply with Rule 144. While the planned sale slightly increases supply, the scale is immaterial to fundamentals and should have limited market impact absent further selling.
FAQ
What is the current stock price of WORK Medical Technology Group (WOK)?
What is the market cap of WORK Medical Technology Group (WOK)?
What is the core business of WORK Medical Technology Group LTD?
Which product categories does the company offer?
How does the company ensure the quality of its products?
What makes WORK Medical Technology Group LTD stand out in the medical consumables market?
How does the company serve the healthcare sector?
What regulatory standards does the company adhere to?
How does the company maintain operational excellence?
How is WORK Medical Technology Group LTD positioned within its competitive landscape?
